Lack of association of KIF6 genotype with vascular disease and statin response

Affiliations

Comment

Kiran Musunuru. Circ Cardiovasc Genet. 2011.

. 2011 Aug 1;4(4):467-8.

doi: 10.1161/CIRCGENETICS.111.960955.

¹ Massachusetts General Hospital, Boston, MA 02114, USA. kiranmusunuru@gmail.com

No abstract available

Comment on

No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
Hopewell JC, Parish S, Clarke R, Armitage J, Bowman L, Hager J, Lathrop M, Collins R; MRC/BHF Heart Protection Study Collaborative Group. Hopewell JC, et al. J Am Coll Cardiol. 2011 May 17;57(20):2000-7. doi: 10.1016/j.jacc.2011.02.015. Epub 2011 Mar 31. J Am Coll Cardiol. 2011. PMID: 21458191 Clinical Trial.
Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention.
Ridker PM, MacFadyen JG, Glynn RJ, Chasman DI. Ridker PM, et al. Circ Cardiovasc Genet. 2011 Jun;4(3):312-7. doi: 10.1161/CIRCGENETICS.110.959353. Epub 2011 Apr 14. Circ Cardiovasc Genet. 2011. PMID: 21493817